Back to search

Article

A genetic risk score to guide age-specific, personalized prostate cancer screening

2016-11-25

Abstract excerpt

<h4>Background</h4> Prostate-specific-antigen (PSA) screening resulted in reduced prostate cancer (PCa) mortality in a large clinical trial, but due to a high false-positive rate, among other concerns, many guidelines do not endorse universal screening and instead recommend an individualized decision based on each patient’s risk. Genetic risk may provide key information to guide the decisions of whether and at wh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
05014be9-b194-5740-ae7c-b43e095b546b
DOI
10.1101/089383
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A genetic risk score to guide age-specific, personalized prostate cancer screeningDOI 10.1101/089383
Select a neighboring publication to make it the new centre.